How can we stamp out high-risk myeloma?
- PMID: 38753353
- DOI: 10.1182/blood.2024024140
How can we stamp out high-risk myeloma?
Comment on
-
Daratumumab, carfilzomib, lenalidomide, and dexamethasone with tandem transplant for high-risk newly diagnosed myeloma.Blood. 2024 May 16;143(20):2029-2036. doi: 10.1182/blood.2023023597. Blood. 2024. PMID: 38394666 Clinical Trial.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical